Altimmune (ALT) Asset Utilization Ratio (2011 - 2025)

Altimmune (ALT) has 15 years of Asset Utilization Ratio data on file, last reported at 0.0 in Q4 2025.

• On a quarterly basis, Asset Utilization Ratio rose 18.12% year-over-year to 0.0 in Q4 2025; TTM through Dec 2025 was 0.0, a 18.12% increase from a year earlier, with the FY2025 full-year figure at 0.0, up 71.12% from the prior year.
• Asset Utilization Ratio for Q4 2025 stood at 0.0, up from 0.0 in the prior quarter.
• Over the last five years, Asset Utilization Ratio for ALT reached as high as 0.04 in Q1 2021 and fell as low as 0.0 in Q3 2025.
• Historically, Asset Utilization Ratio has averaged 0.01 across 5 years, with a median of 0.0 in 2023.
• Across the five-year window, Asset Utilization Ratio sank 98.37% in 2022 and soared 661.51% in 2024, its largest moves.
• Year by year, Asset Utilization Ratio stood at 0.02 in 2021, then sank by 98.37% to 0.0 in 2022, then surged by 617.8% to 0.0 in 2023, then tumbled by 93.83% to 0.0 in 2024, then increased by 18.12% to 0.0 in 2025.
• Per Business Quant data, the three most recent Asset Utilization Ratio figures were 0.0 in Q4 2025, 0.0 in Q3 2025, and 0.0 in Q2 2025.